What Researchers Did
This commentary discusses the overutilization of hyperbaric oxygen therapy (HBOT) in outpatient wound care, its historical evolution, and the impact of prior authorization on access to care.
What They Found
Researchers found widespread overutilization of hyperbaric oxygen therapy (HBOT) in outpatient wound care, noting that while the number of hospitals providing HBOT is at an all-time high, those willing to treat immediate needs are at an all-time low. This has resulted in major population areas lacking 24/7 HBOT availability and inpatient access, leading healthcare purchasers to implement strategies like prior authorization for elective indications.
What This Means for Canadian Patients
Canadian patients might experience similar challenges with access to specialized therapies like HBOT, especially for emergency or inpatient needs, if resource allocation is not carefully managed. Policies regarding prior authorization for elective treatments could impact timely access to care, necessitating a balance between cost control and patient needs within the Canadian healthcare system.
Canadian Relevance
This study primarily discusses issues within the US healthcare system, specifically referencing the Centers for Medicare and Medicaid Services, and therefore has no direct Canadian connection.
Study Limitations
As a commentary, this study's findings are based on expert opinion and historical analysis rather than empirical data or a systematic review, which may introduce author bias.